Fekade B Sime
@b_fekade
Followers
88
Following
121
Media
1
Statuses
29
Joined June 2018
RT @MGilchrist123: Stability of tigecycline in elastomeric devices for OPAT - Tigecycline meets the š¬š§ YCD criteria of ā¤5% degradation limiā¦.
0
8
0
RT @mgetnet21: Our article: has been selected for inclusion in the Best of Journal of Antimicrobial Chemotherapyā¦.
0
3
0
RT @BSACandJAC: āBy standardising stability testing guidelines, we can broaden treatment options for patients with serious infections, imprā¦.
0
5
0
RT @MGilchrist123: Is it time for global harmonization of opat drug stability testing frameworks? Great to collaborate with ā¦ā¦@jasonrobertsā¦.
0
6
0
RT @ABsteward: šļøš„State of the art review article #JAC šs @jasonroberts_pk @b_fekade @MGilchrist123.Current Practices and challenges of outā¦.
0
40
0
RT @MGilchrist123: Great to see this - Evaluation of stability of ceftazidime/avibactam in elastomeric infusion devices used for OPAT. š¬š§ &ā¦.
0
6
0
RT @CRE_RESPOND: You're invited to an exciting 3-day workshop on Antimicrobial Optimisation: Population pharmacokinetic modeling and dosingā¦.
0
4
0
RT @CRE_RESPOND: You're invited to an exciting 3-day workshop on Antimicrobial Optimisation: Population pharmacokinetic modeling and dosingā¦.
0
7
0
Supported by @CRE_REDUCE , we published 33 papers on PK/PD of antimicrobials since 2019. Exting time as we transition to #CRE_RESPOND @jasonroberts_pk #Steategicretreat.
0
3
16
RT @Antiinfectives: Live Roundtable Discussion on .Clinical Trials Targeting Antimicrobial.Resistance with @davidantibiotic ,DR. Mo Yin andā¦.
0
2
0
RT @CRE_REDUCE: Lots happening at CRE REDUCE in the next few months!.Check out our upcoming education events . @jasā¦.
0
3
0
RT @APTlivuni: Itās very nice to āseeā everyone at #ECCMID2021. Iām struck that despite the last 18/12, so little has changed in the #AMRā¦.
0
32
0
RT @MGilchrist123: Hello OPAT / HITH/ IV@home communities - antibiotic stability question for you! What buffers are used in continuous abxā¦.
0
7
0
RT @Critcare_bear: It would make sense that high aminoglycoside concentrations achieved in the lungs after nebulisation would optimise bactā¦.
0
5
0
RT @popatlab: Checkout my point of view on #COVID19Vaccine @AustralianCRS @UQHealth @UQPharmacy Thank you @WolframJoy for creating this beā¦.
0
7
0
RT @EnricoCoiera: [New Paper] Clinician checklist for assessing suitability of machine learning applications in healthcare .
0
17
0